Antidepressant-Associated Mania and Psychosis Resulting in Psychiatric Admissions

Adrian Preda, Rebecca W. MacLean, Carolyn M. Mazure, and Malcolm B. Bowers, Jr.

Published: January 1, 2001

Article Abstract

Background: The safety and tolerability of theselective serotonin reuptake inhibitors and the newer atypicalagents have led to a significant increase in antidepressant use.These changes raise concern as to the likelihood of acorresponding increase in adverse behavioral reactionsattributable to these drugs.

Method: All admissions to a university-basedgeneral hospital psychiatric unit during a 14-month period werereviewed.

Results: Forty-three (8.1%) of 533 patients werefound to have been admitted owing to antidepressant-associatedmania or psychosis.

Conclusion: Despite the positive changes in theside effect profile of antidepressant drugs, the rate ofadmissions due to antidepressant-associated adverse behavioraleffects remains significant.

Volume: 62

Quick Links: Neurologic and Neurocognitive , Neurology

Continue Reading…

Subscribe to read the entire article

$40.00

Buy this Article as a PDF

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Original Research

Sublingual Dexmedetomidine for the Treatment of Acute Agitation in Adults With Schizophrenia or Schizoaffective Disorder: A Randomized Placebo-Controlled Trial

This RCT determined whether a single dose of sublingual dexmedetomidine reduced acute agitation associated with schizophrenia or...

Read More...